weight loss drugs other than glp 1 Foundayo and Wegovy Pills: Side Effects How GLP-1 medications are transforming

The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect

These medications are now recommended for patients with type 2 diabetes and chronic kidney disease to reduce cardiovascular risk and protect renal function

While injectable GLP-1 treatments remain the leading licensed choice for weight loss in the UK today, oral alternatives are quickly closing the gap

Liraglutide, which has been approved for reducing the risk of T2MD, has also been found to reduce the risk of major cardiovascular events in adults with established CVDs ( Table 1 Classification of GLP-1RAs

Pinto LC, Falcetta MR, Rados DV, Leitao CB, Gross JL